Yu Ya Huang, MD
Critical Care Medicine · Chandler, AZNPI 1992851828
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by GSK at 25.3% of the total. Reporting peaked in 2019 at $1,375 and has fallen 78.1% since, to $301 in 2023. Among critical care medicine clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$901
- AstraZeneca$481
- Insmed, Inc.$314
- Boehringer Ingelheim$267
- Genentech USA, Inc.$180
- Grifols USA, LLC$178
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,568100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 72 | $901 |
| AstraZeneca | 24 | $481 |
| Insmed, Inc. | 9 | $314 |
| Boehringer Ingelheim | 16 | $267 |
| Genentech USA, Inc. | 10 | $180 |
| Grifols USA, LLC | 11 | $178 |
| Actelion Pharmaceuticals US, Inc. | 7 | $143 |
| Philips North America LLC | 7 | $135 |
| Electromed, Inc. | 9 | $115 |
| United Therapeutics Corporation | 6 | $115 |
| Sanofi | 5 | $96 |
| Intuitive Surgical | 1 | $90 |
| Jazz Pharmaceuticals Inc. | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 5 | $86 |
| Sunovion Pharmaceuticals Inc. | 5 | $70 |
| Mylan Specialty L.p. | 4 | $64 |
| Advanced Respiratory, Inc | 2 | $43 |
| Amgen | 2 | $43 |
| Merck | 2 | $31 |
| PARI Respiratory Equipment, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Gilead | 1 | $16 |
| Acacia Pharma Inc | 1 | $15 |
| Baxter Healthcare | 1 | $15 |
| Pulmonx Corporation | 1 | $12 |
| Phadia US Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,568 in reported general payments places this provider in the 90th percentile of 175 critical care medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 83 | $97,781 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $27,291 |
| Spiriva HandihalerTiotropium Bromide | 21 | $25,595 |
| Spiriva RespimatTiotropium Bromide | 20 | $23,383 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $15,048 |
| Advair HfaFluticasone Propion/Salmeterol | 27 | $13,005 |
| SymbicortBudesonide/Formoterol Fumarate | 29 | $12,309 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $11,692 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $11,237 |
| Ipratropium Bromide | 73 | $4,065 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $3,719 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 56 | $2,402 |
| Azithromycin | 49 | $1,338 |
| Doxycycline Hyclate | 92 | $1,051 |
| Prednisone | 124 | $515 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $901 | $120,710110 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $481 | $39,60048 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $267 | $38,43131 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 175 critical care medicine providers in Arizona.
Other critical care medicine in Chandler
- Loreto SulitChandler$6K
- Angela MorroneChandler$3K
- Jack ShortChandler$1K
- Kristopher RoachChandler$1K
- Francis MaguireChandler$1K
- Naomi HabibPhoenix$298K
- Heather PrzybylPhoenix$126K
- Douglas MapelPrescott$125K
- Akshay MuralidharScottsdale$44K
- Syed ShahryarPhoenix$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.